Go to:
Logótipo
Você está em: Start > MI075179

Legislation and Regulatory Affairs of Medicinal Products

Code: MI075179     Acronym: LRM

Keywords
Classification Keyword
OFICIAL Social Science

Instance: 2019/2020 - 1S Ícone do Moodle

Active? Yes
Responsible unit: Pharmaceutical Technology Laboratory
Course/CS Responsible: MSc in Pharmaceutical Sciences

Cycles of Study/Courses

Acronym No. of Students Study Plan Curricular Years Credits UCN Credits ECTS Contact hours Total Time
MICF 166 Official Curriculum 5 - 3 52 81

Teaching language

Portuguese

Objectives

To Understand why medicines must  be authorized and the design of the marketing authorization system.

To Know the terminology and concepts used at national and European level in the area of drug law and regulation, namely in pharmaceutical development, elaboration and validation of methods and processes.

To Know and understand the regulation of aspects associated with the material flows, preparation and control of medicinal products for human or veterinary use, as well as with the evaluation of stability and definition of shelf life.

 

Learning outcomes and competences

Prepare pharmacists  to understand and participate in the preparation of a marketing authorization application for a medicinal product, particularly CTD module 3.

Transversal competencies:

-cognitive: analytical and critical skills;

-methodological: time management, planning skills and digital skills;

-social: interpersonal communication and teamwork.

Working method

Presencial

Program

Regulatory framework of the area of the medicine.

Main historical elements in European and North American context.

The construction of a global system and the ICH.

The framework for transnational cooperation of regulatory authorities and the positioning of companies.

 The Regulatory System of the medicinal product in the European Union.

The construction of the Europe of the Medicine.

The European regulations in the field of medicine.

Quality.
Good manufacturing practices.

Biotechnology.

Preclinical safety.

Clinical efficacy and safety.

The European system and its operationalization.

National and decentralized procedure  system (mutual recognition).

Centralized procedure and EMA.
The common technical document (CTD)

The functioning of the CHMP and several CXMP.

 The scientific advice of the EMA/CHMP.

The European coordination of regulatory authorities and the freedom of movement.

Mandatory literature

EMA; EMA Scientifig guidelines

Teaching methods and learning activities

Lectures (2h/week); Theoretical and practical classes (2h/week): Power Point presentations.  The teacher in charge is available for attendance of students  by appointment.

Evaluation Type

Distributed evaluation with final exam

Assessment Components

designation Weight (%)
Exame 60,00
Trabalho escrito 40,00
Total: 100,00

Amount of time allocated to each course unit

designation Time (hours)
Estudo autónomo 40,00
Frequência das aulas 40,00
Trabalho escrito 20,00
Total: 100,00

Eligibility for exams

The student’s assistance to lectures is not obligatory.

Calculation formula of final grade

The final grade is weighted as follows: 60% of the written test + 40% of theoretical-practical work.  Students with final scores equal to or greater than 9.5 values are considered approved.  Students with final scores less than 9.5 values are considered  not approved.

Recommend this page Top
Copyright 1996-2025 © Faculdade de Farmácia da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-12-03 at 11:37:50 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book